← Evidence map

ArticleClinical pharmacology and therapeutics2026

Bemnifosbuvir: An HCV NS5B Inhibitor With Multiple Modes of Action.

Carolin Zitzmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 42183606